Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia

Daewoong Pharmaceutical

Status: Unknown

Conditions: Hypertension; Dyslipidemias

Treatments: Drug: Other: Not applicable-observational study

Study type: Observational

Funder types: Industry

Identifiers

NCT03009721

DW_DOLO003

Details and patient eligibility

About

The purpose of this study is to investigate the effectiveness and safety of Olostar Tab in patients with essential hypertension and dyslipidemia

Enrollment: 9,707 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female ≥ 19
• Patients have record of blood pressure (SBP/DBP) and LDL-C after prescription of Olostar Tab.

Exclusion criteria

• Patients that have participated clinical trials or PMS with Olostar Tab.